Compare VRA & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRA | RANI |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.7M | 126.8M |
| IPO Year | 2010 | 2021 |
| Metric | VRA | RANI |
|---|---|---|
| Price | $4.07 | $0.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 271.8K | ★ 1.4M |
| Earning Date | 06-10-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.47 | ★ 57.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $416,097,000.00 | $1,633,000.00 |
| Revenue This Year | N/A | $274.77 |
| Revenue Next Year | $2.50 | $79.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 58.85 |
| 52 Week Low | $1.39 | $0.39 |
| 52 Week High | $4.30 | $3.87 |
| Indicator | VRA | RANI |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 44.86 |
| Support Level | $1.96 | $0.45 |
| Resistance Level | N/A | $1.54 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 75.13 | 58.52 |
Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.